Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Anaptysbio (ANAB) Leases (2019 - 2025)

Anaptysbio (ANAB) has disclosed Leases for 7 consecutive years, with $12.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Leases fell 12.96% year-over-year to $12.5 million, compared with a TTM value of $12.5 million through Dec 2025, down 12.96%, and an annual FY2025 reading of $12.5 million, down 12.96% over the prior year.
  • Leases was $12.5 million for Q4 2025 at Anaptysbio, down from $13.0 million in the prior quarter.
  • Across five years, Leases topped out at $20.3 million in Q2 2021 and bottomed at $218000.0 in Q1 2021.
  • Average Leases over 5 years is $15.7 million, with a median of $16.4 million recorded in 2023.
  • The sharpest move saw Leases tumbled 82.03% in 2021, then surged 8683.03% in 2022.
  • Year by year, Leases stood at $19.6 million in 2021, then decreased by 8.49% to $17.9 million in 2022, then dropped by 9.63% to $16.2 million in 2023, then decreased by 11.07% to $14.4 million in 2024, then fell by 12.96% to $12.5 million in 2025.
  • Business Quant data shows Leases for ANAB at $12.5 million in Q4 2025, $13.0 million in Q3 2025, and $13.5 million in Q2 2025.